Skip to content

Vaginal misoprostol for first trimester termination of pregnancy prior to 9 weeks of gestation

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN18011364
Enrollment
80
Registered
2002-10-14
Start date
1998-01-01
Completion date
Unknown
Last updated
2015-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Medical abortion Pregnancy and Childbirth Abortion

Interventions

Patients will be randomised into two groups: 1. Group one will be treated using misoprostol with three drops of water (the 'water group') 2. Group two will only use misoprostol (the 'no water group')

Sponsors

Hong Kong Health Services Research Fund (Hong Kong)
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: 1. The duration of menstrual delay is less than 49 days 2. The size of the uterus on pelvic examination is compatible with the estimated duration of pregnancy 3. A positive pregnancy test 4. There is no history of significant medical illness 5. Age greater than 16 years old 6. Requests legal termination of pregnancy

Exclusion criteria

Exclusion criteria: 1. History or evidence of disorders that represent a contraindication to the use of misoprostol (mitral stenosis, glaucoma, sickle cell anaemia, diastolic pressure >100 mm Hg, bronchial asthma) 2. History or evidence of thrombo-embolism, severe or recurrent liver disease or pruritus of pregnancy 3. Presence of intrauterine contraceptive device (IUCD) in utero 4. Suspect or proven ectopic pregnancy 5. Heavy smoker (smoking >10 cigarettes daily in the past 2 years) or had another risk factor for cardiovascular disease

Design outcomes

Primary

MeasureTime frame
Not provided at time of registration

Secondary

MeasureTime frame
Not provided at time of registration

Countries

Hong Kong

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026